The prostate cancer clinical trials consortium: application for coordinating center with affiliate clinical research sites
Active Cooperative Agreement Awarded Last action
- Award ID
- HT9425262E001
- Recipient
-
Sloan-Kettering Institute For Cancer Research UEI KUKXRCZ6NZC2
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $10,500,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 3% complete
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $10.5 million Cooperative Agreement to Sloan-Kettering Institute for Cancer Research on September 30, 2026, to establish and operate the Prostate Cancer Clinical Trials Consortium as a coordinating center with affiliate clinical research sites. The award funds the consortium's infrastructure, coordination, and clinical research operations through the Military Medical Research and Development program (CFDA 12.420).
Performance runs through September 29, 2030, with place of performance in New York, New York. The coordinating center will support multi-site clinical trials and research activities across the consortium's affiliate network, serving to advance prostate cancer research and treatment solutions relevant to the Department of Defense and broader public health.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of California, LOS Angeles | $250,000 | |
| Thomas Jefferson University | $250,000 |
Quick answers
Who received award HT9425262E001?
HT9425262E001 was awarded to Sloan-Kettering Institute For Cancer Research by Defense Health Agency (Department of Defense) on September 30, 2026.
How much is award HT9425262E001 worth?
$10,500,000 has been obligated on HT9425262E001.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award